左心室辅助装置支持患者的残余二尖瓣反流——INTERMACS分析
基于INTERMACS注册研究2006至2017年8364例连续流左心室辅助装置患者,18.8%存在残余二尖瓣反流;残余二尖瓣反流与更差左室重构、更多右室功能障碍及更高右心压力相关,并增加右心衰竭和肾衰竭风险,死亡风险呈升高趋势。
要点
- 连续流左心室辅助装置患者中18.8%在装置支持前3个月内出现中度或重度残余二尖瓣反流。
- 年轻、女性、非缺血性心衰及基线左室舒张末内径增大、右室功能障碍、重度二尖瓣或三尖瓣反流、右心压力升高为残余二尖瓣反流预测因素。
- 同期二尖瓣修复可降低残余二尖瓣反流风险;残余二尖瓣反流与右心衰竭和肾衰竭风险增加相关,死亡风险呈升高趋势。
核心结论
- 残余二尖瓣反流与左心室辅助装置支持患者更差的临床结局相关。
- 作者建议对存在残余二尖瓣反流的左心室辅助装置患者考虑包括药物和装置优化以及瓣膜修复在内的策略以减少二尖瓣反流。
研究设计与样本
- 回顾性分析INTERMACS注册研究中2006年至2017年接受连续流左心室辅助装置且既往未行二尖瓣修复的患者。
- 残余二尖瓣反流定义为装置支持前3个月内中度或重度二尖瓣反流。
- 共纳入8364例患者,比较有或无残余二尖瓣反流患者的基线特征、超声心动图和血流动力学变量及临床结局。
主要发现
- 8364例患者中18.8%存在残余二尖瓣反流。
- 年轻、女性、非缺血性心衰、左室舒张末内径增大、右室功能障碍、基线重度二尖瓣反流或三尖瓣反流及右心压力升高是残余二尖瓣反流的预测因素。
- 同期二尖瓣修复降低残余二尖瓣反流风险。
- 残余二尖瓣反流患者在几乎全部分析时间点显示更差左室重构、更多右室功能障碍和更高右心压力。
- 残余二尖瓣反流与右心衰竭和肾衰竭风险增加相关,死亡风险呈升高趋势。
临床怎么用
- 作者建议对存在残余二尖瓣反流的左心室辅助装置患者考虑包括药物和装置优化以及瓣膜修复在内的策略以减少二尖瓣反流。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular assist device (LVAD) placement frequently leads to a reduction in the severity of functional mitral regurgitation (MR). However, a significant number of LVAD supported patients have residual MR. We sought to assess the impact of residual MR in LVAD patient outcomes. METHODS: Patients in the INTERMACS registry who received a continuous flow LVAD between 2006 and 2017 without a prior mitral valve repair were included for analysis. Residual MR was defined as moderate or severe MR within the first 3 months device support. Baseline characteristics, echocardiographic and hemodynamic variables, and clinical outcomes were comparatively analyzed between those with or without residual MR. RESULTS: A total of 8,364 patients were included in the study, of which 18.8% demonstrated residual MR. Younger age, female gender, and non-ischemic heart failure were predictors of residual MR, as were increased LVEDD, RV dysfunction, severe baseline MR or TR, and elevated right heart pressures. Concomitant mitral valve repair reduced the risk of residual MR. Those with residual MR demonstrated worse LV remodeling, more right ventricular dysfunction, and higher right heart pressures at almost all time points analyzed. Residual MR was associated with increased risk of right heart failure and renal failure, and a trend toward increased mortality on LVAD support. CONCLUSIONS: Residual MR is associated with worse clinical outcomes on LVAD support. Strategies to minimize MR including medical and device optimization as well as valve repair should be considered in LVAD patients with residual MR.
引用
- Jain R, Truby LK, Topkara VK, et al. Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis. J Heart Lung Transplant. 2022. PMID: 35379546. doi:10.1016/j.healun.2022.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。